Ibex: Latest version of Galen™ transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user-interface, and workflow integration capabilities   Tel Aviv, Israel, September 4, 2022 – Ibex Medical...

Ibex: Pathologists who used Ibex’s Galen™ Breast for cancer diagnosis obtained very high accuracy in a multi-site clinical study. Tel Aviv, Israel, September 1, 2022 - Ibex Medical Analytics, the leader in AI-powered cancer diagnostics,...

Ibex: Galen™ Gastric demonstrated outstanding outcomes in detecting gastric cancer in a multi-site study, supporting quality diagnosis, enhanced lab efficiency and quality control Tel Aviv, Israel, June 15, 2022 – Ibex Medical...

Ibex: Hartford HealthCare is participating in a pioneering research initiative to use artificial intelligence technology to help pathologists with cancer diagnosis and to improve patient care HARTFORD, CT – Ibex Medical Analytics, a...

Milan, March 10th, 2022 – Dedalus Group ("Dedalus"), the leading healthcare and diagnostic software solutions provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer...

ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer...